Skip to content

Esoxx Reflux Protection & Acid Defence

by Sofar Swiss SA EUDAMED

Active European Union

Ref EXX-C30LModel MELT IN MOUTH TABLETS

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number764015897GERDOFFSE Basic UDI-DIDate15 Oct 2025RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/MDR Active

Certificates

2 certificates · EUDAMED

EUDAMED certificates (2)
  • CSQ0028250925 Supplemented

    Quality management system EU MDR

    Issued
    26 May 2025
    Expires
    23 Apr 2030
    Reason
    Add device or group
  • CVD0043250725 Supplemented

    Technical documentation EU MDR

    Issued
    14 May 2025
    Expires
    23 Apr 2030
    Reason
    Change approved

Specification

EUDAMED

Model / Reference
MELT IN MOUTH TABLETS, EXX-C30L
Primary DI / UDI-DI
07640158970775
Basic UDI-DI
764015897GERDOFFSE
Direct Marketing DI
07640158970775
EMDN Code
G99 Gastrointestinal devices - other
Device Class
Class III
Market of Registration
Hungary

Manufacturer details

EUDAMED SRN
CH-MF-000047475
Authorised representative
ALFASIGMA S.P.A. IT-AR-000047395

Other devices from Sofar Swiss SA

See all devices from Sofar Swiss SA →

Properties

Show properties
  • Animal Tissues
Other properties (12)
  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No